AstraZeneca PLC (AZNCF)
OTCMKTS · Delayed Price · Currency is USD
190.99
+2.49 (1.32%)
At close: Jan 9, 2026
AstraZeneca Market Cap
AstraZeneca has a market cap or net worth of $295.57 billion as of January 9, 2026. Its market cap has increased by 46.38% in one year.
Market Cap
295.57B
Enterprise Value
320.06B
Revenue
58.13B
Ranking
n/a
PE Ratio
31.45
Stock Price
$190.99
Market Cap Chart
Since May 28, 1993, AstraZeneca's market cap has increased from 7.10B to 295.57B, an increase of 4,062.37%. That is a compound annual growth rate of 12.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 295.57B | 2.69% |
| Dec 31, 2025 | 287.81B | 41.66% |
| Dec 31, 2024 | 203.17B | -2.91% |
| Dec 29, 2023 | 209.27B | -0.08% |
| Dec 30, 2022 | 209.44B | 15.06% |
| Dec 31, 2021 | 182.03B | 38.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Glass House Brands | 723.98M |
| Elite Pharmaceuticals | 506.04M |
| Northwest Biotherapeutics | 405.74M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 352.88M |
| Silence Therapeutics | 273.96M |